The impact of ANLN on persistence of estrogen receptor positive breast cancer was shown by respective experiments showing a cell-cycle arrest in G2/M, lowered expression of cyclins D1, A2, and B1, as well as altered cell morphology [103]. This evidence concerns the gene ESR1 and breast carcinoma.